​
​

CERo Therapeutics Ownership 2024 | Who Owns CERo Therapeutics Now?

OverviewFinancialsChart

Institutional Ownership

26.30%

Insider Ownership

95.20%

Retail Ownership

-21.50%

Institutional Holders

9.00

CERo Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SC CHINA HOLDING LTD----149,999-100.00%-Jun 30, 2024
KESTRA PRIVATE WEALTH SERVICES, LLC----10,000-100.00%-Jun 30, 2024

CERo Therapeutics's largest institutional shareholder is SC CHINA HOLDING LTD, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SC CHINA HOLDING LTD----149,999-100.00%-Jun 30, 2024
KESTRA PRIVATE WEALTH SERVICES, LLC----10,000-100.00%-Jun 30, 2024

The largest CERo Therapeutics shareholder by % of total assets is SC CHINA HOLDING LTD. The company owns 0.00 shares of CERo Therapeutics (PBAX), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
KESTRA PRIVATE WEALTH SERVICES, LLC----10,000-100.00%-Jun 30, 2024
SC CHINA HOLDING LTD----149,999-100.00%-Jun 30, 2024

As of Jun 30 2024, CERo Therapeutics's largest institutional buyer is KESTRA PRIVATE WEALTH SERVICES, LLC. The company purchased -10.00K stocks of PBAX, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SC CHINA HOLDING LTD----149,999-100.00%-Jun 30, 2024
KESTRA PRIVATE WEALTH SERVICES, LLC----10,000-100.00%-Jun 30, 2024

As of Jun 30 2024, CERo Therapeutics's biggest institutional seller is SC CHINA HOLDING LTD. The company sold -0.15M shares of PBAX, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SC CHINA HOLDING LTD----149,999-100.00%-Jun 30, 2024
KESTRA PRIVATE WEALTH SERVICES, LLC----10,000-100.00%-Jun 30, 2024

CERo Therapeutics's largest sold out institutional shareholder by shares sold is SC CHINA HOLDING LTD, sold -0.15M shares, valued at -, as of undefined.

CERo Therapeutics Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
MERGER FUND0.07%561,074--Mar 28, 2024
NEXPOINT FUNDS I0.06%217,482--Dec 31, 2023
MERGER FUND VL0.05%7,198--Mar 28, 2024
Investment Managers Series Trust II0.03%426,692--Jan 31, 2024
Saba Capital Income & Opportunities Fund0.02%57,685--Jan 31, 2024
RIVERNORTH OPPORTUNITIES FUND, INC.0.01%10,588--Jan 31, 2024
Virtus Event Opportunities Trust0.00%10,636--Mar 28, 2024
Blackstone Alternative Investment Funds0.00%153,800--Mar 31, 2023
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.0.00%13,488--Mar 31, 2023
Tidal ETF Trust0.00%7,486--Jan 31, 2024
CALAMOS INVESTMENT TRUST/IL0.00%25,000--Jan 31, 2024
FIRST TRUST ALTERNATIVE OPPORTUNITIES FUND0.00%646--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%10,588--Feb 29, 2024
PRINCIPAL FUNDS, INC.0.00%898--Feb 29, 2024

CERo Therapeutics's largest mutual fund holder by % of total assets is "MERGER FUND", owning 561.07K shares, compromising 0.07% of its total assets.

CERo Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 249-10.00%
31 Dec, 2310-
30 Sep, 2310-28.57%
30 Jun, 2314-6.67%
31 Mar, 2315-67.39%
31 Dec, 2246-28.13%
30 Sep, 226418.52%
30 Jun, 225420.00%
31 Mar, 224528.57%
31 Dec, 2135-

As of 31 Mar 24, 9 institutions are holding CERo Therapeutics's shares, representing a decrease of -10.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 241,665,17299.60%
31 Dec, 23834,2660.50%
30 Sep, 23830,140-26.64%
30 Jun, 231,131,580-14.87%
31 Mar, 231,329,272-86.50%
31 Dec, 229,849,202-34.10%
30 Sep, 2214,945,1774.76%
30 Jun, 2214,266,6323.99%
31 Mar, 2213,719,23133.00%
31 Dec, 2110,315,400-

CERo Therapeutics (PBAX) has 1.67M shares outstanding as of 31 Mar 24, up 99.60% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2426.30%15.15%
31 Dec, 2313.17%7.67%
30 Sep, 2313.11%4.69%
30 Jun, 2316.72%4.34%
31 Mar, 2319.64%0.09%
31 Dec, 22145.49%0.30%
30 Sep, 22220.77%0.50%
30 Jun, 22210.75%0.51%
31 Mar, 22202.66%0.87%
31 Dec, 21152.38%-

As of 31 Mar 24, CERo Therapeutics is held by 26.30% institutional shareholders, representing a 15.15% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 248300.00%
31 Dec, 232100.00%
30 Sep, 231-80.00%
30 Jun, 23566.67%
31 Mar, 233-83.33%
31 Dec, 2218-48.57%
30 Sep, 223534.62%
30 Jun, 222618.18%
31 Mar, 2222-37.14%
31 Dec, 2135-

8 institutional shareholders have increased their position in PBAX stock as of 31 Mar 24 compared to 2 in the previous quarter (a 300.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24--100.00%
31 Dec, 231-66.67%
30 Sep, 233-
30 Jun, 233-40.00%
31 Mar, 235-28.57%
31 Dec, 22740.00%
30 Sep, 225-
30 Jun, 225-16.67%
31 Mar, 226-
31 Dec, 21--

- institutional shareholders have reduced their position in PBAX stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 249-10.00%1,665,17299.60%26.30%15.15%8300.00%--100.00%
31 Dec, 2310-834,2660.50%13.17%7.67%2100.00%1-66.67%
30 Sep, 2310-28.57%830,140-26.64%13.11%4.69%1-80.00%3-
30 Jun, 2314-6.67%1,131,580-14.87%16.72%4.34%566.67%3-40.00%
31 Mar, 2315-67.39%1,329,272-86.50%19.64%0.09%3-83.33%5-28.57%
31 Dec, 2246-28.13%9,849,202-34.10%145.49%0.30%18-48.57%740.00%
30 Sep, 226418.52%14,945,1774.76%220.77%0.50%3534.62%5-
30 Jun, 225420.00%14,266,6323.99%210.75%0.51%2618.18%5-16.67%
31 Mar, 224528.57%13,719,23133.00%202.66%0.87%22-37.14%6-
31 Dec, 2135-10,315,400-152.38%-35---

CERo Therapeutics Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 12, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-J-OtherSell82,875--4,596,250
Oct 12, 2021Ehrlich Christopher Bdirector, 10 percent owner, officer CEO and SecretaryJ-OtherSell82,875--4,596,250
Oct 05, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-Sell---663,263
Oct 05, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-Sell4,679,125---
Oct 05, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-Sell331,632$11.50$3.81M-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 12, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-J-OtherSell82,875--4,596,250
Oct 12, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-J-OtherBuy36,733$10.00$367.33K699,996
Oct 12, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-J-OtherBuy18,366$11.50$211.21K349,998
Oct 12, 2021Ehrlich Christopher Bdirector, 10 percent owner, officer CEO and SecretaryJ-OtherSell82,875--4,596,250
Oct 12, 2021Ehrlich Christopher Bdirector, 10 percent owner, officer CEO and SecretaryJ-OtherBuy36,733$10.00$367.33K699,996
Oct 12, 2021Ehrlich Christopher Bdirector, 10 percent owner, officer CEO and SecretaryJ-OtherBuy18,366$11.50$211.21K349,998
Oct 12, 2021Geffken Daniel E.officer Chief Financial OfficerJ-OtherBuy30,000--30,000
Oct 12, 2021Loewy Caroline Mdirector-J-OtherBuy17,500--17,500
Oct 12, 2021Fisher Douglasofficer PresidentJ-OtherBuy100,000--100,000
Oct 12, 2021Fisher Douglasofficer PresidentJ-OtherBuy10,000--10,000
Oct 12, 2021Fisher Douglasofficer PresidentJ-OtherBuy5,000$11.50$57.50K5,000
Oct 12, 2021LAPORTE KATHLEENdirector-J-OtherBuy17,500--17,500
Oct 12, 2021ATWOOD BRIAN Gdirector-J-OtherBuy25,000--25,000
Oct 12, 2021Kosacz Barbaradirector-J-OtherBuy17,500--17,500
Oct 05, 2021ATWOOD BRIAN Gdirector Buy----
Oct 05, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-Sell---663,263
Oct 05, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-Sell4,679,125---
Oct 05, 2021PHOENIX BIOTECH SPONSOR, LLC10 percent owner-Sell331,632$11.50$3.81M-
Oct 05, 2021Ehrlich Christopher Bdirector, 10 percent owner, officer CEO and and SecretaryBuy---663,263
Oct 05, 2021Ehrlich Christopher Bdirector, 10 percent owner, officer CEO and and SecretaryBuy4,679,125---

The last insider sell of CERo Therapeutics's stock was made by PHOENIX BIOTECH SPONSOR, LLC on Oct 12 2021, selling 82,875 shares at - per share (valued at -).

CERo Therapeutics Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio

CERo Therapeutics Peer Ownership

TickerCompany
TGAATarget Global Acquisition I Corp.

PBAX Ownership FAQ

CERo Therapeutics is owned by institutional shareholders (26.30%), insiders (95.20%), and public (-21.50%). The largest institutional shareholder of CERo Therapeutics is SC CHINA HOLDING LTD (0% of total shares) and the top mutual fund owner is MERGER FUND (0.07% of total shares).

CERo Therapeutics's major institutional shareholders are SC CHINA HOLDING LTD, and KESTRA PRIVATE WEALTH SERVICES, LLC. The top five shareholders own together 0% of the company's share outstanding.

As of Mar 2024, there are 9 institutional shareholders of CERo Therapeutics.

SC CHINA HOLDING LTD owns 0 shares of CERo Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).

As of Jun 2024, KESTRA PRIVATE WEALTH SERVICES, LLC holds 0 shares of CERo Therapeutics (PBAX), compromising 0% of the company, valued at $0.